Analysis of compliance with oral contraception in Spain

Parrilla, Juan José; Coll, C.; Bajo, J.M.; Balasch, Juan; Calaf, Joaquím; Caño, África; Díez, Èlia; Dueñas, José Luís; Lete, Iñaki; Matínez, J.; Novo, Alexandre; Rodriguez-Escudero, F.J.; Roncales, J. M.; Serrano, Isabel

doi:10.3109/13625189609150680

Cited by 6 publications

(2 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 2 The high rates of UP in Spain might be related to the high use of SARC which, to be effective, need to be associated with user compliance. National surveys show a substantial rate of non-compliance affecting oral contraception, 22 and inconsistent use of condoms (20.0% of users), particularly by young people. 23 These two contraceptive methods are the most commonly used in Spain.…”

Section: Discussionmentioning

confidence: 99%

Economic Burden of Contraception Management in Spain

Ribes¹,

Poza

Campos

et al. 2018

JHEOR

View full text Add to dashboard Cite

Background: A wide variety of contraceptive methods are available, some of them reimbursed by the Spanish National Health System (SNHS). However, the number of unintended pregnancies (UP) is still significant, leading to a high economic burden, mainly derived from non-adherence to and the incorrect use of contraceptive methods. Objectives: This study aims to estimate the economic burden associated with reversible contraception management in Spain, from the perspectives of both the SNHS and women, over a 5-year period. Methods: A survey was performed to identify contraception management in Spain based on the experience of a panel of six expert gynecologists. An economic model was conducted to quantify the current burden of contraception according to healthcare resources use over 5 years. The costs included in the analysis were diagnostic tests, initial and follow-up consultations, methods acquisition costs, and UP derived from therapy failure. Results: Reversible contraception costs in Spain amount to €12.5 billion over a 5–year period. Condoms and combined oral contraceptives (COC) account for 86.8% of the total cost and the other methods only 13.2%. There are differences in contraceptive use according to women’s age. Short-acting reversible contraceptives (SARC) such as COC, condom and vaginal ring, are most commonly used by younger women. However, SARC are correlated with the highest failure rate, resulting in over €7.2 billion cost, explained by the high number of UP. Long-acting reversible contraceptives (LARC), such as the levonorgestrel-releasing intrauterine system (LNG-IUS20), implant and copper intrauterine devices (IUD), are selected by women over 35 years of age due to user-independent compliance. SARC methods result in a higher cost per woman over 5 years: vaginal ring €2427.8, patch €2402.6, condom €2060.1 and COC €1895.1; while LARC methods are the most economic option per women: LNG-IUS20 €630.4, copper IUD €658.2, LNG-IUS12 €703.8, intramuscular injectable €907.8 and implant €940.5. Conclusions: LARC methods result in lower costs compared with SARC options from the perspectives of the SNHS and women, explained by user-independent compliance, preventing a significant number of UP and its elevated economic burden. An increased LARC methods use could avoid UP events, leading to significant cost-savings for the SNHS.

show abstract

Section: Discussionmentioning

confidence: 99%

Economic Burden of Contraception Management in Spain

Ribes¹,

Poza

Campos

et al. 2018

JHEOR

View full text Add to dashboard Cite

show abstract

“…Although a decrease in dose has been achieved together with a reduction in secondary effects, without any loss of effectiveness of the pill, there are still many women who are reluctant to use this type of birth control method. Studies have shown that in some developed countries (for example, Spain), only a small percentage of women of fertile age take OCs, and many of them do not take the pill on a regular basis 7,8 .…”

mentioning

confidence: 99%